These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 13121078)

  • 1. Relative inability of heparin to prolong clotting time of oxalated and resin-treated blood and plasma.
    SALOMON L; STEFANINI M
    Proc Soc Exp Biol Med; 1953 Nov; 84(2):476-8. PubMed ID: 13121078
    [No Abstract]   [Full Text] [Related]  

  • 2. Coagulation protein function VI: augmentation of anticoagulant function by acetaldehyde-treated heparin.
    Brecher AS; Hellman K; Basista MH
    Dig Dis Sci; 1999 Jul; 44(7):1349-55. PubMed ID: 10489917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of clotting tests augmented by heparin.
    WEINER M; JIMINEZ M
    Am J Clin Pathol; 1956 Mar; 26(3):243-6. PubMed ID: 13302169
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of heparin on the early stages of blood coagulation.
    O'BRIEN JR
    J Clin Pathol; 1960 Mar; 13(2):93-8. PubMed ID: 14428016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the sensitivity of an in vitro high frequency ultrasound device to monitor the coagulation process: study of the effects of heparin treatment in a murine model.
    Callé R; Rochefort GY; Desbuards N; Plag C; Antier D; Ossant F
    Ultrasound Med Biol; 2010 Feb; 36(2):295-305. PubMed ID: 20045589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of a new one-stage clotting assay for heparin and low molecular weight heparins.
    Harenberg J
    J Mal Vasc; 1987; 12 Suppl B():68-70. PubMed ID: 2834495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An improved plasma recalcified clotting test and its modification as a simple rapid heparin retarded clotting test.
    EASTHAM RD
    J Clin Pathol; 1962 Jan; 15(1):86-7. PubMed ID: 13888970
    [No Abstract]   [Full Text] [Related]  

  • 8. The influence of temperature upon the heparin and citrate clotting times.
    LOSNER S; VOLK BW
    Am J Med Sci; 1953 Jul; 226(1):60-4. PubMed ID: 13065283
    [No Abstract]   [Full Text] [Related]  

  • 9. Low-dose heparin in gynecologic surgery: effect on blood coagulation tests.
    Levesque G; Samama M; Kher A; Barbier P; Horellou MH; Conard J
    Haemostasis; 1981; 10(2):97-103. PubMed ID: 7461507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of correction between activated clotting time and plasma heparin during cardiopulmonary bypass.
    Pi KD
    Ann Surg; 1983 Jul; 198(1):115. PubMed ID: 6859985
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of heparin on three whole blood activated clotting tests and thrombin time.
    Uden DL; Seay RE; Kriesmer PJ; Cipolle RJ; Payne NR
    ASAIO Trans; 1991; 37(2):88-91. PubMed ID: 1854557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Plasma prothrombin-proconvertin content following therapeutic doses of heparin].
    MUNCK O
    Ugeskr Laeger; 1956 Jan; 118(2):38-9. PubMed ID: 13312131
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter: The heparin thrombin clotting-time.
    Green PJ
    Lancet; 1975 Apr; 1(7910):799. PubMed ID: 48020
    [No Abstract]   [Full Text] [Related]  

  • 14. Coagulation protein function: enhancement of the anticoagulant effect of acetaldehyde by sulfated glycosaminoglycans.
    Brecher AS; Adamu MT
    Dig Dis Sci; 2001 Sep; 46(9):2033-42. PubMed ID: 11575460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of caronamide and heparin on the coagulation time of human blood.
    SIRAK HD; McCLEERY RS; ARTZ CP
    Health Cent J; 1948 Mar; 1(2):112. PubMed ID: 18934526
    [No Abstract]   [Full Text] [Related]  

  • 16. Coagulation of oxalated plasma without calcium following neutralization of heparin by toluidine blue.
    MYSLIVECEK J
    Nature; 1949 Apr; 163(4146):605. PubMed ID: 18208299
    [No Abstract]   [Full Text] [Related]  

  • 17. An improved method for evaluation of blood coagulation in heparinized blood.
    Cowan JF; Khan MB; Vargo J; Joist JH
    Am J Clin Pathol; 1981 Jan; 75(1):60-4. PubMed ID: 7457430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clotting factor assays on plasma from patients receiving intramuscular of subcutaneous heparin.
    RAPAPORT SI; AMES SB
    Am J Med Sci; 1957 Dec; 234(6):678-86. PubMed ID: 13487576
    [No Abstract]   [Full Text] [Related]  

  • 19. Rivaroxaban and dabigatran did not affect clotting profiles in plasma reconstituted with varying levels of autologous platelets to the same degree as heparin when evaluated using thromboelastography.
    Gantioqui J; Stevic I; Atkinson H; Chan AKC
    Blood Coagul Fibrinolysis; 2018 Sep; 29(6):521-527. PubMed ID: 29965810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coagulation protein function: the influence of acetaldehyde-modified heparin on thrombin activity.
    Brecher AS; Fu Q
    J Investig Med; 1999 Jan; 47(1):76-80. PubMed ID: 10071484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.